Olanzapine

Product NDC: 65862-565
Requested package NDC: 65862-565-71
11-digit product format: 658620565
Labeler code: 65862
Product ID: 65862-565_e10b90de-4a0a-413e-a5f9-6978a183b568
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Olanzapine
Dosage form: TABLET
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA202050
Marketing category: ANDA
Marketing start: 2012-04-23
Substance: OLANZAPINE
Active strength: 15 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	65862-565	65862-565-71	UNFINISHED	Active or certified unfinished drug listing		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A202050-001	OLANZAPINE	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23
A202050-002	OLANZAPINE	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23
A202050-003	OLANZAPINE	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23
A202050-004	OLANZAPINE	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23
A202050-005	OLANZAPINE	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23
A202050-006	OLANZAPINE	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
A202050-001	AB
A202050-002	AB
A202050-003	AB
A202050-004	AB
A202050-005	AB
A202050-006	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-005	OLANZAPINE	15MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-006	OLANZAPINE	20MG	TABLET / ORAL	AB	2012-04-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-001	OLANZAPINE	2.5MG	TABLET / ORAL	AB	2012-04-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-002	OLANZAPINE	5MG	TABLET / ORAL	AB	2012-04-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-003	OLANZAPINE	7.5MG	TABLET / ORAL	AB	2012-04-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-004	OLANZAPINE	10MG	TABLET / ORAL	AB	2012-04-23	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A202050-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-005	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202050-006	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202050-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202050-006	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202050-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202050-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202050-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202050-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202050-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202050-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202050-004	AB	1	`b8a1b40f171c…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Olanzapine
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
OLANZAPINE	15 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
N7U69T4SZR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
200034	Internal RxNorm lookup
283639	Internal RxNorm lookup
312077	Internal RxNorm lookup
312078	Internal RxNorm lookup
312079	Internal RxNorm lookup
314154	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
636665be-9d7e-443a-8134-e8cc47e6ba24	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
42e9462d-db65-453b-8069-8fb2df9182e8	Product name	1	20211216
12d02c27-e8da-47f1-b815-ccca982731ef	Product name	9	20170802
877783eb-030c-6e3f-0979-804cf94d8856	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-565-01	Olanzapine	100 in 1 BOTTLE	TABLET	100	21
65862-565-10	Olanzapine	10 in 1 BLISTER PACK	TABLET	10	21
65862-565-10	Olanzapine	10 in 1 CARTON	TABLET	10	21
65862-565-30	Olanzapine	30 in 1 BOTTLE	TABLET	30	21
65862-565-99	Olanzapine	1000 in 1 BOTTLE	TABLET	1000	21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-565-30	EA - Each	65862-565	c09099d0-20a7-441c-b81a-cf0167481422	1	2012-07-24
65862-565-99	EA - Each	65862-565	7b745ecc-17a6-4151-94ed-f8dbd501e561	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-565	OLANZAPINE TABLET [AUROBINDO PHARMA LIMITED]	20	Current NDC, Legacy NDC, 5 package rows	20250306_636665be-9d7e-443a-8134-e8cc47e6ba24.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Olanzapine	OLANZAPINE	Bryant Ranch Prepack	4e90e30c-78a1-486f-a13c-f1ff798216be	2026-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202050 application number: ANDA202050
Olanzapine	OLANZAPINE	Aurobindo Pharma Limited	636665be-9d7e-443a-8134-e8cc47e6ba24	2026-02-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 202050 application number: ANDA202050 ndc (product): 65862-565

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N7U69T4SZR	OLANZAPINE	132539-06-1	OLANZAPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
314154	OLANZapine 10 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312077	OLANZapine 15 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
200034	OLANZapine 2.5 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
283639	OLANZapine 20 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312078	OLANZapine 5 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312079	OLANZapine 7.5 MG Oral Tablet	PSN	636665be-9d7e-443a-8134-e8cc47e6ba24	21
314154	olanzapine 10 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312077	olanzapine 15 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21
200034	olanzapine 2.5 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21
283639	olanzapine 20 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312078	olanzapine 5 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21
312079	olanzapine 7.5 MG Oral Tablet	SCD	636665be-9d7e-443a-8134-e8cc47e6ba24	21

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Status
65862-565-71	65862056571	7000 TABLET in 1 BAG (65862-565-71)	7000 tablet	23-APR-12	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Olanzapine	Aurobindo Pharma Limited \| Aurolife Pharma LLC	2026-02-10	Human Prescription Drug Label	21